Purchase Order 75N91019P00825
Award Date 9/23/19
Potential Completion Date 7/22/20
Potential Value $250K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Piscataway, NJ 08854, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a Firm Fixed Price Purchase Order to GenScript USA Inc., a for-profit biotechnology company, to provide DETECTION OF MUTATION-REACTIVE T CELLS IN PATIENTS WITH METASTATIC CANCERS. The contract has a potential value of $849,989.66 and a completion date of September 21, 2019. The contract does not have a set-aside designation. GenScript USA Inc. has a history of providing customized DNA,...
- This is a $3,078,000.00 firm fixed-price contract awarded by the National Cancer Institute (NCI) to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The contract is for the provision of gene synthesis, peptide synthesis, and quality control analysis services to support the NCI Surgery Branch's clinical research efforts on mutation-reactive T-cells for the treatment of metastatic cancers. The contract has a 12-month base period with two 12-month option periods. There...
- This federal contract award is to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey, for $3,903.76. The contract is a delivery order with a firm fixed price, awarded by the National Cancer Institute, which is a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS). The contract is for "Peptide Services" and does not have a set-aside designation. Genscript, a for-profit organization, has received...
- This federal contract award to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey, was issued by the National Cancer Institute, a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services. The $4,217.03 firm fixed-price delivery order is for peptide services and does not have a set-aside designation. Genscript is a major provider of molecular biology products and services to federal agencies, including the NIH, Centers...
- This firm fixed price purchase order was awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Cancer Institute to Genscript USA Inc., a for-profit biotechnology company based in Piscataway, New Jersey. The $15,289.00 contract will run through September 30, 2024 and does not have a set-aside designation. Genscript specializes in gene synthesis, gene editing, custom protein and antibody production, and other molecular biology services that support...
- This federal contract award to Genscript USA Inc., a biotechnology company, was issued by the National Cancer Institute, which is part of the Department of Health and Human Services' National Institutes of Health. The $17,250.82 firm fixed price purchase order is for the provision of biological products and services, with a completion date of June 26, 2024. Genscript has previously received other prime federal contracts to supply customized DNA, antibodies, proteins, and other materials for...
- This is a firm fixed-price delivery order awarded by the National Cancer Institute (NCI), a civilian agency within the Department of Health and Human Services (HHS), to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The contract, valued at $8,872.00, is for "PEPTIDE SERVICES/GENSCRIPT/GAL CAFRI" and does not have a set-aside designation. Genscript, a for-profit organization, has a long history of providing a wide range of molecular biology products and...
- This federal contract award to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey, is for PEPTIDE SERVICES/GENSCRIPT/MARIA PARKHURST. The $3,222.30 firm fixed-price delivery order was awarded on September 4, 2015 by the National Cancer Institute, a component of the Department of Health and Human Services. The contract, which does not have a set-aside designation, supports Genscript's provision of a range of molecular biology products and services, including gene...
- This is a firm fixed-price delivery order awarded by the National Cancer Institute (NCI), a civilian agency within the Department of Health and Human Services (HHS), to Genscript USA Inc., a for-profit biotechnology company based in Piscataway, New Jersey. The $3,464.90 contract is for peptide services and was awarded on September 8, 2015 with a completion date of September 9, 2015. The award does not have a set-aside designation. Genscript has received numerous prime and subcontracts from...
- This contract was awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Cancer Institute to Genscript USA Inc., a for-profit biotechnology company based in Piscataway, New Jersey. The $3,182.40 firm fixed price delivery order is for gene synthesis services. Genscript specializes in providing customized DNA, antibodies, proteins, peptides, and other molecular biology products and services to support biomedical research and public health initiatives...